SCHEMBL4713138

SCHEMBL4713138

Cc1cccc(C=Cc2ccc(NC(=O)CNC(=O)OC(C)(C)C)cc2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43
NPC1 O15118 1/20 0.43
GRM5 P41594 1/20 0.43
RAB9A P51151 1/20 0.43
GRM4 Q14833 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
PKM P14618 1/20 0.43
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43
NFKB1 P19838 1/20 0.43
CYP2C19 P33261 1/20 0.43
THPO P40225 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4712992 0.90 AURKB (0.45) ALDH1A1HDAC6NPC1GRM5RAB9A
SCHEMBL4712993 0.90 AURKB (0.45) ALDH1A1HDAC6NPC1GRM5RAB9A
SCHEMBL4713462 0.79 NPC1 (0.52) ALDH1A1HDAC6NPC1GRM5RAB9A
SCHEMBL4713464 0.79 NPC1 (0.52) ALDH1A1HDAC6NPC1GRM5RAB9A
SCHEMBL8693590 0.78 CA1 (0.54) ALDH1A1HDAC6RAB9AMEN1PKM
SCHEMBL3220737 0.77 CA1 (0.47) ALDH1A1HDAC6NPC1RAB9AKDM4E
SCHEMBL4710057 0.77 KMT2A (0.54) ALDH1A1HDAC6NPC1GRM5RAB9A
SCHEMBL4710056 0.77 KMT2A (0.54) ALDH1A1HDAC6NPC1GRM5RAB9A
SCHEMBL4711829 0.76 RAB9A (0.56) ALDH1A1HDAC6NPC1GRM5RAB9A
SCHEMBL4711830 0.76 RAB9A (0.56) ALDH1A1HDAC6NPC1GRM5RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0998459-B1 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2008-04-23 EP claimed
EP-0998459-B1 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2008-04-23 EP disclosed